243 related articles for article (PubMed ID: 36810117)
1. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
[TBL] [Abstract][Full Text] [Related]
2. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses.
Kim SC; Park JW; Seo HY; Kim M; Park JH; Kim GH; Lee JO; Shin YK; Bae JM; Koo BK; Jeong SY; Ku JL
Adv Sci (Weinh); 2022 Feb; 9(5):e2103360. PubMed ID: 34918496
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
[TBL] [Abstract][Full Text] [Related]
4. Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer.
Marisa L; Blum Y; Taieb J; Ayadi M; Pilati C; Le Malicot K; Lepage C; Salazar R; Aust D; Duval A; Blons H; Taly V; Gentien D; Rapinat A; Selves J; Mouillet-Richard S; Boige V; Emile JF; de Reyniès A; Laurent-Puig P
Clin Cancer Res; 2021 Sep; 27(17):4768-4780. PubMed ID: 34168047
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
Okamoto T; duVerle D; Yaginuma K; Natsume Y; Yamanaka H; Kusama D; Fukuda M; Yamamoto M; Perraudeau F; Srivastava U; Kashima Y; Suzuki A; Kuze Y; Takahashi Y; Ueno M; Sakai Y; Noda T; Tsuda K; Suzuki Y; Nagayama S; Yao R
Stem Cell Reports; 2021 Apr; 16(4):954-967. PubMed ID: 33711267
[TBL] [Abstract][Full Text] [Related]
6. Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
Bruun J; Kryeziu K; Eide PW; Moosavi SH; Eilertsen IA; Langerud J; Røsok B; Totland MZ; Brunsell TH; Pellinen T; Saarela J; Bergsland CH; Palmer HG; Brudvik KW; Guren T; Dienstmann R; Guren MG; Nesbakken A; Bjørnbeth BA; Sveen A; Lothe RA
Clin Cancer Res; 2020 Aug; 26(15):4107-4119. PubMed ID: 32299813
[TBL] [Abstract][Full Text] [Related]
7. Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer.
Okamoto T; Natsume Y; Doi M; Nosato H; Iwaki T; Yamanaka H; Yamamoto M; Kawachi H; Noda T; Nagayama S; Sakanashi H; Yao R
Cancer Sci; 2022 Aug; 113(8):2693-2703. PubMed ID: 35585758
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
Wang S; Wang Y; Xun X; Zhang C; Xiang X; Cheng Q; Hu S; Li Z; Zhu J
J Exp Clin Cancer Res; 2020 Jan; 39(1):22. PubMed ID: 31992334
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics.
Bhatia S; Kramer M; Russo S; Naik P; Arun G; Brophy K; Andrews P; Fan C; Perou CM; Preall J; Ha T; Plenker D; Tuveson DA; Rishi A; Wilkinson JE; McCombie WR; Kostroff K; Spector DL
Cancer Res; 2022 Apr; 82(7):1174-1192. PubMed ID: 35180770
[TBL] [Abstract][Full Text] [Related]
10. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
[TBL] [Abstract][Full Text] [Related]
12. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
Tiriac H; Belleau P; Engle DD; Plenker D; Deschênes A; Somerville TDD; Froeling FEM; Burkhart RA; Denroche RE; Jang GH; Miyabayashi K; Young CM; Patel H; Ma M; LaComb JF; Palmaira RLD; Javed AA; Huynh JC; Johnson M; Arora K; Robine N; Shah M; Sanghvi R; Goetz AB; Lowder CY; Martello L; Driehuis E; LeComte N; Askan G; Iacobuzio-Donahue CA; Clevers H; Wood LD; Hruban RH; Thompson E; Aguirre AJ; Wolpin BM; Sasson A; Kim J; Wu M; Bucobo JC; Allen P; Sejpal DV; Nealon W; Sullivan JD; Winter JM; Gimotty PA; Grem JL; DiMaio DJ; Buscaglia JM; Grandgenett PM; Brody JR; Hollingsworth MA; O'Kane GM; Notta F; Kim E; Crawford JM; Devoe C; Ocean A; Wolfgang CL; Yu KH; Li E; Vakoc CR; Hubert B; Fischer SE; Wilson JM; Moffitt R; Knox J; Krasnitz A; Gallinger S; Tuveson DA
Cancer Discov; 2018 Sep; 8(9):1112-1129. PubMed ID: 29853643
[TBL] [Abstract][Full Text] [Related]
13. Ileal Derived Organoids From Crohn's Disease Patients Show Unique Transcriptomic and Secretomic Signatures.
Niklinska-Schirtz BJ; Venkateswaran S; Anbazhagan M; Kolachala VL; Prince J; Dodd A; Chinnadurai R; Gibson G; Denson LA; Cutler DJ; Jegga AG; Matthews JD; Kugathasan S
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1267-1280. PubMed ID: 34271224
[TBL] [Abstract][Full Text] [Related]
14. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
15. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
Papaccio F; García-Mico B; Gimeno-Valiente F; Cabeza-Segura M; Gambardella V; Gutiérrez-Bravo MF; Alfaro-Cervelló C; Martinez-Ciarpaglini C; Rentero-Garrido P; Zúñiga-Trejos S; Carbonell-Asins JA; Fleitas T; Roselló S; Huerta M; Sánchez Del Pino MM; Sabater L; Roda D; Tarazona N; Cervantes A; Castillo J
J Exp Clin Cancer Res; 2023 Jan; 42(1):8. PubMed ID: 36604765
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer.
Maru Y; Kohno M; Suzuka K; Odaka A; Masuda M; Araki A; Itami M; Tanaka N; Hippo Y
Hum Cell; 2024 May; 37(3):840-853. PubMed ID: 38546950
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.
Prince E; Cruickshank J; Ba-Alawi W; Hodgson K; Haight J; Tobin C; Wakeman A; Avoulov A; Topolskaia V; Elliott MJ; McGuigan AP; Berman HK; Haibe-Kains B; Cescon DW; Kumacheva E
Nat Commun; 2022 Mar; 13(1):1466. PubMed ID: 35304464
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural analysis of breast cancer patient-derived organoids.
Signati L; Allevi R; Piccotti F; Albasini S; Villani L; Sevieri M; Bonizzi A; Corsi F; Mazzucchelli S
Cancer Cell Int; 2021 Aug; 21(1):423. PubMed ID: 34376194
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
Hogstrom JM; Cruz KA; Selfors LM; Ward MN; Mehta TS; Kanarek N; Philips J; Dialani V; Wulf G; Collins LC; Patel JM; Muranen T
J Biol Chem; 2023 Aug; 299(8):105021. PubMed ID: 37423299
[TBL] [Abstract][Full Text] [Related]
20. An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers.
Wang B; Gan J; Liu Z; Hui Z; Wei J; Gu X; Mu Y; Zang G
J Exp Clin Cancer Res; 2022 Dec; 41(1):350. PubMed ID: 36527158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
